Literature DB >> 3659254

Non-convulsive status epilepticus: a prospective study in an adult general hospital.

J W Dunne1, Q A Summers, E G Stewart-Wynne.   

Abstract

A prospective study of non-convulsive status epilepticus was undertaken in order to evaluate the occurrence and characteristics of this condition in adults. The diagnosis was established in 22 of 113 patients (19 per cent) presenting with status epilepticus over a 23-month period. Non-convulsive status was most prevalent in the over 60 age group. Its two subgroups, absence status (18 cases) and complex partial status (four cases) were both manifest clinically by a prolonged alteration of consciousness of variable extent. Absence status presented de novo (six cases) or against a background of epilepsy (12 cases), often with a long seizure-free interval before presentation. Precipitating factors included infection, inadequate anticonvulsant medication and benzodiazepine withdrawal. The clouding of consciousness was usually characterised by confusion, disorientation and partial responsiveness. Myoclonic or clonic movements of the eyes, face or jaw were evident in all but two patients. Automatisms, including ambulatory behaviour (three cases) were less common. Serious psychiatric disorders preceded the status in seven cases, and contributed to the difficulty in diagnosis. Complex partial status was associated with underlying cerebrovascular disease in three of four cases, and is characterised by a more severe and variable clouding of consciousness, less frequent facial clonic movements, episodic adversive head and eye movements, and a more gradual recovery after treatment.

Entities:  

Mesh:

Year:  1987        PMID: 3659254

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  10 in total

1.  Continuous or emergent EEG: can bedside caregivers recognize epileptiform discharges?

Authors:  Enrique C Leira; Mary E Bertrand; R Edward Hogan; Salvador Cruz-Flores; Kathleen W Wyrwich; Osamah J Albaker; Eve M Holzemer
Journal:  Intensive Care Med       Date:  2003-11-13       Impact factor: 17.440

Review 2.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

3.  Prolonged complex partial status epilepticus: a case report.

Authors:  M A Roberts; P R Humphrey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

4.  Emergency EEG and factors associated with nonconvulsive status epilepticus.

Authors:  R B Khan; P K Yerremsetty; D Lindstrom; L J McGill
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

5.  Jarisch-Herxheimer reaction in a patient with neurosyphilis: non-convulsive status epilepticus?

Authors:  N Heye; J W Dunne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

6.  Treatment of nonconvulsive status epilepticus.

Authors:  Trudy Pang; Frank W Drislane
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

Review 7.  Nonconvulsive status epilepticus in adults - insights into the invisible.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

8.  Feasibility study of a caregiver seizure alert system in canine epilepsy.

Authors:  Lisa D Coles; Edward E Patterson; W Douglas Sheffield; Jaideep Mavoori; Jason Higgins; Bland Michael; Kent Leyde; James C Cloyd; Brian Litt; Charles Vite; Gregory A Worrell
Journal:  Epilepsy Res       Date:  2013-08-18       Impact factor: 3.045

9.  Complex partial status epilepticus: a recurrent problem.

Authors:  O C Cockerell; M C Walker; J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

Review 10.  Non-Convulsive Status Epilepticus in the Presence of Catatonia: A Clinically Focused Review.

Authors:  Dax C Volle; Katharine G Marder; Andrew McKeon; John O Brooks; Jennifer L Kruse
Journal:  Gen Hosp Psychiatry       Date:  2020-11-13       Impact factor: 3.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.